Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Remyelination therapy goes to trial for multiple sclerosis
4-aminopyridine toxicity: a case report and review of the literature.
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Dynamic regulatory network controlling TH17 cell differentiation.
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
The mystery of missing heritability: Genetic interactions create phantom heritability.
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.
Vitamin D intake and incidence of multiple sclerosis.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
Prospective memory, emotional valence, and multiple sclerosis.
Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis.
Copolymer 1 inhibits manifestations of graft rejection.
Combination Treatment of Interferon β-1b and Warfarin for a Patient With Baló's Concentric Sclerosis and Antiphospholipid Syndrome.

Pages